This inventor holds 2 USPTO granted patents. Top assignees: Akita University, Arkay, Inc.. Active years: 2015-2018.
Company Filing History:
2 out of 32 
1 out of 3 Years Active: 2015-2018
Title: Satoru Motoyama: Innovator in Cancer Detection
Introduction
Satoru Motoyama is a notable inventor based in Akita, Japan. He has made significant contributions to the field of cancer detection, particularly in the area of lymph node metastasis. With a total of 2 patents, his work is recognized for its clinical significance and potential impact on treatment strategies.
Latest Patents
Motoyama's latest patents include a method for determining lymph node metastasis in cancer or the risk thereof, along with a rapid determination kit for the same. The objective of this invention is to provide a method and means of rapidly and reliably detecting lymph node metastasis in cancer. Specifically, it identifies a certain genetic polymorphism of the human CRP gene, which is crucial for effective prediction and determination regarding lymph node metastasis. This innovation is clinically significant as it aids in determining treatment strategies, which is vital in cancer progression.
Career Highlights
Throughout his career, Satoru Motoyama has worked with esteemed institutions such as Akita University and Arkay, Inc. His experience in these organizations has contributed to his expertise in cancer research and innovation.
Collaborations
Motoyama has collaborated with notable colleagues, including Junichi Ogawa and Masatomo Miura. These partnerships have further enhanced his research and development efforts in the field of cancer detection.
Conclusion
Satoru Motoyama's contributions to cancer detection through his innovative patents highlight his commitment to improving medical outcomes. His work continues to pave the way for advancements in the understanding and treatment of cancer.